Log in Book a Demo

US Pharma & Biotech Cardiology - PPC Market Share Analysis April 2026

Leveraging Adthena’s Whole Market View, this analysis explores recent trends in Google Ads for the US Cardiology category from the last month. Our Data Analyst, Ask Arlo provides commentary on key findings.

Cardiology – US

Google AI Overview visibility for Pharma & Biotech Cardiology US

See how often AIOs appear and how search intent is distributed across buying signals.

See more data

AIO Frequency

How often a Google AI overview appears on search terms relevant to this category.

Frequency Percentage
Frequency 48.4865557374
51.5134442626
48%

Complex Query Frequency

A complex query is a longer, more detailed search that often contains multiple keywords, specific conditions, or multi-part questions.

Frequency Percentage
Frequency 19
81
19%

Search Intent Distribution

Breakdown of search queries by their underlying goal.

Intent Distribution
Investigational 2%
Transactional 7%
Navigational 0%
Seasonal 0%
Local 0%
Problem Solving 22%

Copyright © Adthena. All rights reserved.

Market Exposure

Share of Clicks for top 10 US Pharma & Biotech Cardiology brands

Here are the Top 10 competitors in the industry by Share of Clicks for the last month.

See more data
Share of Clicks - Last month
Share of Clicks - Last month
Domain Share of clicks
repatha.com 58.57
repathahcp.com 15.45
lipitor.com 6.77
veltassa.com 4.55
leqvio.com 2.47
leqviohcp.com 1.74
goodrx.com 1.3
thorne.com 0.98
lifeextension.com 0.83
vyndamax.com 0.81
others 6.53
  • repatha.com - 58.57%
  • repathahcp.com - 15.45%
  • lipitor.com - 6.77%
  • veltassa.com - 4.55%
  • leqvio.com - 2.47%
  • leqviohcp.com - 1.74%
  • goodrx.com - 1.3%
  • thorne.com - 0.98%
  • lifeextension.com - 0.83%
  • vyndamax.com - 0.81%
  • others - 6.53%

Copyright © Adthena. All rights reserved.

In the PPC landscape, repatha.com dominates with 58.57% click share, followed by repathahcp.com at 15.45%. Lipitor.com and others hold 6.77% and 6.53%, respectively.

Market Exposure

Share of Spend for the top 10 US Pharma & Biotech Cardiology brands

Curious about your market position? Here you can see the Top 10 competitors in the industry by Share of Spend for the last month. 

See more data
Share of Spend - Last Month
Share of Spend - Last Month
Date repatha.com repathahcp.com lipitor.com vyndamax.com veltassa.com vyndamax.pfizerpro.com leqviohcp.com leqvio.com thorne.com nexlizethcp.com
2026/04/01 58.65% 14.11% 0.04% 2.08% 9.43% 1.76% 0.49% 0.19% 1.85% 0.74%
2026/04/02 49.03% 16.86% 0.67% 0.48% 11.06% 0.43% 1.86% 1.38% 1.73% 1.95%
2026/04/03 58.08% 18.29% 0.53% 1.4% 6.83% 1.1% 1.64% 1.5% 1.09% 1.22%
2026/04/04 64.21% 19.78% 0.16% 0.55% 4.22% 0.45% 1.48% 0.76% 0.9% 0.69%
2026/04/05 53.97% 16.02% 16.15% 0.96% 3.53% 0.86% 0.82% 0.24% 0.69% 0.49%
2026/04/06 59.8% 22.33% 4.42% 0.62% 3.36% 0.51% 0.86% 0.91% 0.82% 0.81%
2026/04/07 60.89% 17.42% 9.85% 0.49% 2.24% 0.38% 1.6% 0.88% 0.55% 0.64%
2026/04/08 59.13% 13.93% 6.02% 0.96% 3.42% 0.68% 1.1% 1.09% 0.83% 1.52%
2026/04/09 64.84% 17.32% 0.37% 1.57% 4.64% 0.99% 1.62% 0.04% 0.38% 0.49%
2026/04/10 65.38% 18.04% 0.31% 0.88% 3.57% 0.61% 2.23% 0.41% 0.73% 0.76%
2026/04/11 69.44% 17.12% 0.1% 0.49% 3.95% 0.43% 0.92% 0.27% 0.74% 0.34%
2026/04/12 67.18% 16.84% 1.23% 0.65% 3.08% 0.44% 2.34% 1.11% 0.79% 0.41%
2026/04/13 56.9% 16.61% 6.51% 1.39% 3.67% 1.35% 3.29% 0.64% 0.7% 0.62%
2026/04/14 51.99% 20.45% 1.43% 1.69% 4.61% 1.24% 4.21% 1.42% 1.92% 0.83%
2026/04/15 67.25% 16.74% 0.15% 1.49% 3.32% 0.98% 2.51% 1.11% 0.58% 1.51%
2026/04/16 64.9% 16.95% 0.11% 1.21% 4.02% 0.75% 2.38% 2.2% 0.1% 0.76%
2026/04/17 66.77% 16.42% 0.13% 0.31% 2.52% 0.17% 1.75% 2.6% 0.54% 2.37%
2026/04/18 54.42% 15.4% 9.56% 0.83% 3.18% 0.69% 2.44% 3.6% 0.55% 1.41%
2026/04/19 61.62% 19.33% 0.7% 0.33% 3.09% 0.16% 2.8% 4.94% 0.35% 1.1%
2026/04/20 58.64% 15.26% 10.8% 0.3% 4.27% 0.17% 2.86% 1.75% 0.41% 1.03%
2026/04/21 67.12% 18.11% 0.23% 0.25% 2.7% 0.14% 2.21% 5.45% 0.47% 0.38%
2026/04/22 64.4% 14.43% 4.32% 0.29% 2.22% 0.17% 1.89% 7.74% 0.4% 0.29%
2026/04/23 63.31% 16.77% 0.2% 0.27% 4.81% 0.13% 1.53% 7.85% 0.58% 0.36%
2026/04/24 64.79% 14.41% 0.38% 1.11% 3.4% 0.83% 1.87% 7.05% 0.82% 0.7%
2026/04/25 62.39% 16.69% 0.71% 0.75% 2.69% 0.48% 2.05% 7.88% 0.34% 0.04%
2026/04/26 59.19% 18.49% 1.02% 1.41% 3.48% 1.04% 2.37% 7.64% 0.69% 0.79%
2026/04/27 54.35% 17.36% 0.41% 3.32% 6.73% 1.95% 3.41% 6.78% 1.11% 0.76%
2026/04/28 58.63% 15.74% 5.44% 1.79% 3.48% 1.29% 0.61% 6.99% 0.57% 0.15%
2026/04/29 64.14% 15.31% 0.26% 2.57% 4.4% 1.63% 2.06% 4.18% 0.36% 0.33%
2026/04/30 64.62% 15.41% 7.12% 2.69% 1.82% 1.7% 1.13% 1% 0.71% 0.21%
  • repatha.com
  • repathahcp.com
  • lipitor.com
  • vyndamax.com
  • veltassa.com
  • vyndamax.pfizerpro.com
  • leqviohcp.com
  • leqvio.com
  • thorne.com
  • nexlizethcp.com

Copyright © Adthena. All rights reserved.

In April 2026, repatha.com dominated PPC spend, peaking mid-month. Repathahcp.com maintained a steady presence, while lipitor.com saw sporadic spikes. Vyndamax.com and veltassa.com showed consistent activity. Leqvio.com surged late month, ending strong.

Market Exposure

Competitor Count for US Pharma & Biotech Cardiology

Ever wondered how many competitors you’re up against in your industry? Well look no further, here we can see the number of advertisers bidding over the last month. 

See more data
Competitor Count - Last month
Competitor Count - Last month
Date Competitor Count
2026/04/01 36
2026/04/02 41
2026/04/03 44
2026/04/04 39
2026/04/05 40
2026/04/06 42
2026/04/07 43
2026/04/08 43
2026/04/09 39
2026/04/10 42
2026/04/11 42
2026/04/12 40
2026/04/13 44
2026/04/14 41
2026/04/15 40
2026/04/16 35
2026/04/17 34
2026/04/18 40
2026/04/19 38
2026/04/20 37
2026/04/21 40
2026/04/22 38
2026/04/23 36
2026/04/24 39
2026/04/25 37
2026/04/26 40
2026/04/27 34
2026/04/28 38
2026/04/29 35
2026/04/30 36

Copyright © Adthena. All rights reserved.

April began with 36 advertisers, peaking at 44 mid-month. A decline followed, ending with 36.

Campaign Efficiency

Market Loss & Market Gains for US Pharma & Biotech Cardiology

Here we’re looking at the Top 10 biggest industry movers by market share gains and losses for the last 30 days.

See more data
Market Loss & Market Gains - Last month
Market Loss & Market Gains - Last month
Name Market Trend
leqvio.com 3.61%
repatha.com 1.97%
chihealth.com 0.37%
leqviohcp.com 0.33%
familywize.org 0.24%
bmscustomerconnect.com -0.42%
goodrx.com -0.64%
lifeextension.com -0.67%
repathahcp.com -0.84%
lipitor.com -1.79%

Copyright © Adthena. All rights reserved.

Lipitor.com saw a significant drop of 1.79, while Leqvio.com surged by 3.61. Repatha.com gained 1.97, contrasting with Repathahcp.com’s decline of 0.84.

Campaign Efficiency

US Pharma & Biotech Cardiology Share of Impressions

Take a look at the Top 10 competitors in the industry by Share of Impressions over the last month.

See more data
Date repatha.com repathahcp.com lipitor.com telyrx.com leqvio.com leqviohcp.com thorne.com veltassa.com nexlizethcp.com amvuttra.com
2026/04/01 27.27% 23.28% 0.07% 0.06% 0.44% 1.16% 7.41% 8.3% 2.48% 2.98%
2026/04/02 22.38% 21.6% 0.51% 0.05% 1.75% 3.42% 5.41% 7.88% 4.15% 4.96%
2026/04/03 26.37% 29.91% 0.56% 0.29% 2.08% 3.78% 4.36% 5.77% 2.3% 3.75%
2026/04/04 28.89% 34.48% 0.32% 0.02% 2.17% 4.04% 3.6% 3.75% 1.97% 2.85%
2026/04/05 20.7% 22.33% 35.17% 0.11% 0.77% 1.84% 1.96% 2.3% 1.24% 1.44%
2026/04/06 27.69% 33.59% 13.22% 0.02% 2.09% 1.17% 2.67% 2.57% 2.27% 1.09%
2026/04/07 27.38% 23.88% 27.79% 0.02% 1.92% 2.85% 1.63% 1.6% 1.39% 1.66%
2026/04/08 24.93% 19.16% 16.9% 0.02% 2.06% 2.5% 2.7% 2.48% 3.59% 1.91%
2026/04/09 28.87% 31.06% 0.45% 2.29% 0.05% 4.59% 1.32% 4.07% 1.25% 1.67%
2026/04/10 34.11% 30.29% 0.49% 0.02% 2.12% 4.84% 2.65% 2.97% 2.29% 1.29%
2026/04/11 36.39% 33.9% 0.18% 0.1% 0.88% 2.8% 3.06% 3.86% 0.97% 1.64%
2026/04/12 37.66% 30.63% 1.69% 0.01% 1.71% 6.24% 2.93% 2.82% 1.16% 1.24%
2026/04/13 26.36% 22.48% 17.67% 0% 1.39% 6.49% 2.06% 2.59% 1.22% 0.94%
2026/04/14 23.78% 29.49% 1.45% 0.28% 2.68% 9.1% 5.88% 3.3% 2% 2.4%
2026/04/15 34.19% 30.34% 0.23% 0.29% 2.27% 7.15% 2.36% 3.08% 4.1% 2.12%
2026/04/16 33.56% 31.18% 0.13% 0.01% 5.9% 5.68% 0.33% 3.34% 2.29% 1.17%
2026/04/17 33.5% 28.17% 0.23% 0.64% 7.35% 4.72% 1.9% 2.12% 6.19% 3.14%
2026/04/18 23.16% 19.76% 24.07% 0% 8.7% 3.93% 1.59% 1.99% 2.77% 0.73%
2026/04/19 26.97% 30.44% 1.29% 0.01% 12.7% 6.82% 1.12% 2.51% 3.5% 2.97%
2026/04/20 23% 20.31% 31.95% 0.58% 3.94% 5.36% 1.15% 2.83% 2.44% 1.12%
2026/04/21 29.02% 25.87% 0.53% 15.83% 13.23% 4.9% 1.35% 1.73% 0.84% 1.04%
2026/04/22 28.5% 22.28% 12.8% 1.02% 18.17% 3.88% 1.29% 1.66% 0.66% 0.94%
2026/04/23 32.75% 26.61% 0.32% 0% 20.72% 3.74% 1.74% 3.63% 0.97% 1.29%
2026/04/24 32.9% 25.06% 0.55% 0% 18.88% 4.04% 2.91% 2.79% 1.35% 0.41%
2026/04/25 30.4% 26.44% 0.91% 0% 19.76% 4.83% 1.22% 2.05% 0.09% 1.01%
2026/04/26 28.22% 28.45% 0.96% 0% 19.19% 4.85% 2.35% 2.63% 1.87% 0.82%
2026/04/27 24.47% 26.94% 0.69% 0% 17.13% 7.41% 3.67% 5.14% 2.03% 1.51%
2026/04/28 27.58% 22.8% 15.14% 1.14% 17.75% 1.27% 1.74% 2.44% 0.26% 1.11%
2026/04/29 27.85% 26.02% 0.34% 11.6% 10.34% 5.07% 1.27% 3.56% 0.89% 2.3%
2026/04/30 26.5% 22.89% 19.34% 14.25% 2.41% 2.24% 2.22% 1.24% 0.48% 0.44%
  • repatha.com
  • repathahcp.com
  • lipitor.com
  • telyrx.com
  • leqvio.com
  • leqviohcp.com
  • thorne.com
  • veltassa.com
  • nexlizethcp.com
  • amvuttra.com

Copyright © Adthena. All rights reserved.

In April 2026, Repatha.com led with fluctuating impressions, peaking mid-month. Repathahcp.com followed closely, while Lipitor.com showed sporadic spikes. Leqvio.com and Leqviohcp.com gained momentum, ending strong. Overall, Repatha.com maintained dominance.

Campaign Efficiency

Google Text Ad Copy Insights & Creative Trends for US Pharma & Biotech Cardiology

Ever wondered how your rivals’ ads are doing? Here we can see the top-performing ads in the industry over the last month.

See more data
Google Text Ad Copy Insights & Creative Trends for US Pharma & Biotech Cardiology - Last month
  1. 1
    LEQVIO® (inclisiran) - LEQVIO® Side Effects & Results https://www.leqvio.com/patients/sign-up

    View LEQVIO® Dosing Schedule.

  2. 2
    LEQVIO® (inclisiran) HCP Site - Injection Treatment Option https://www.leqviohcp.com/efficacy

    Understand How LEQVIO® May Work To Treat Your Patients. Watch A Mechanism Of Action Video.

  3. 3
    Cardiologists at Mayo Clinic - Don't Pause on Your Health https://www.mayoclinic.org

    Be Treated like a Person, Not Just a Patient by World-class Cardiologists at Mayo Clinic.

  4. 4
    Repatha® (evolocumab) - Official Site For Patients https://www.repatha.com/

    Visit the Official Patient Website for Product Information About Repatha. Learn More About Financial Support And Coverage.

  5. 5
    Repatha® (evolocumab) - Dosing & Administration https://www.repathahcp.com/

    Learn More About Repatha by Visiting the Official Product Website for Physicians. Watch Videos & Discover Insights from Healthcare Professionals...

Copyright © Adthena. All rights reserved.

In the competitive world of cardiology PPC ads, LEQVIO® and Repatha® dominate with distinct strategies. LEQVIO® emphasizes patient education and healthcare professional engagement, while Repatha® focuses on comprehensive patient support and physician insights. Mayo Clinic stands out by humanizing patient care, offering a personal touch.

Frequently Asked Questions

Customer Success Stories

the7stars achieves Google Ads PPC campaign optimization​ with Adthena

Leveraging Adthena's comprehensive insights, the7stars and their lottery client optimized their PPC campaigns and organic strategies, resulting in substantial cost savings and improved campaign performance. Read case study

Sage case study: 75% decrease in CPCs with Adthena

Sage, a leading UK software provider, used Adthena’s brand protection strategy to curb rising CPC costs. By identifying brand infringements and optimizing spend, they effectively strengthened their brand protection strategy and increased ROI.Read case study

Vodafone case study: Driving click share and sales with strategic insights from Adthena

Vodafone used Adthena data to optimize results from the launch of the Samsung S22 product. Combining Adthena’s Strategic Insights with Google Smart Bidding, Vodafone was able to maintain a flexible strategy that leveraged both manual and automated bidding. Leveraging Adthena’s Search Term Opportunities report also allowed Vodafone to implement 27 keyword terms across their business line, driving an increase in revenue at a positive ROAS.Read case study

Get the full picture

See this data specific to your brand performance

The data on this page is just a sample of the billions of data points we hold at Adthena. The insights generated by Ask Arlo, leverage real-time GenAI to answer questions about your search data.

Our search consultants can introduce you to Whole Market View data that is specific to your organization, based on the size of the relevant search term and competitor universe, and the locations that you need monitoring.